ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.40791dup (p.Lys13598fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV004018150 SCV004848582 likely pathogenic Primary dilated cardiomyopathy 2021-09-21 criteria provided, single submitter clinical testing The p.Lys11030GlufsX11 variant in TTN has not been previously reported in individuals with cardiomyopathy nor in large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 11030 and leads to a premature termination codon 11 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. TTN truncating variants encoded in constitutive exons (PSI >95%) have been found to be significantly associated with dilated cardiomyopathy (DCM) regardless of their position in titin (Roberts 2015 PMID:25589632, Schafer 2017 PMID:27869827). The p.Lys11030GlufsX11 variant is located in such a highly expressed exon in the I-band. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal dominant DCM. ACMG/AMP Criteria applied: PVS1, PM2_Supporting.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.